Leif Gunnar Håkansson
Algemeen Directeur bij CanImGuide Therapeutics AB
Profiel
Leif Gunnar Håkansson is the founder of CanImGuide Therapeutics AB.
Prior to founding the company, he worked as the Head of Clinical Tumor Immunology Division at the University of Linköping and as an Associate Professor at the University of Lund.
He holds a doctorate degree from the University of Lund.
Actieve functies van Leif Gunnar Håkansson
| Bedrijven | Functie | Begin |
|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Algemeen Directeur | - |
Eerdere bekende functies van Leif Gunnar Håkansson
| Bedrijven | Functie | Einde |
|---|---|---|
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | Corporate Officer/Principal | - |
| University of Lund | Corporate Officer/Principal | - |
Opleiding van Leif Gunnar Håkansson
| University of Lund | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
